Journal of Biomedical Materials Research Part A · 2016 · 40 citations · 49 references
EngineeringImmunologyImmune RegulationImmunodominanceImmunotherapeuticsCd4 T Cell ResponsesImmune SystemImmunotherapyIntrinsic Immunogenic ActivityBeta Amino EstersSynthetic ImmunologyImmunochemistryPolymer ChemistrySynthetic MacromoleculeImmunoengineeringPolymeric CarriersTherapeutic VaccineHumoral ImmunityT Cell ImmunityBiomolecular EngineeringPolymer ScienceImmunomodulationDendritic Cell BiologyVaccine DesignMolecular WeightMedicine
Polymeric carriers are ubiquitously studied in vaccine and drug delivery to control the encapsulation, kinetics, and targeting of cargo. Recent research reveals many polymers can cause immunostimulatory and inflammatory responses, even in the absence of other immune signals. However, the extent to which this intrinsic immunogenicity evolves during degradation is understudied. Here we synthesized a small library of poly(beta amino esters) (PBAEs) that exhibit different starting molecular weights (MWs), but with similar and rapid degradation rates. Primary dendritic cells (DCs) treated with free PBAEs, either intact or degraded to form low MW fragments, were not activated. In contrast particles formed from PBAEs at different extents of degradation caused differential expression of classical DC activation markers (for example, CD40, CD80, CD86, MHCII), as well as antigen presentation. During degradation, activation levels changed with changing physicochemical properties (for example, MW, concentration, size, charge). Of note, irrespective of starting MW, immunogenicity peaked when the MW of degrading PBAEs decreased to a range of ∼1500-3000 Da. These findings could help inform design of future carriers that exploit the dynamic interactions with the immune system as materials degrade, leading to carriers that deliver cargo but also help direct the immune responses to vaccine or immunotherapy cargo. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 1219-1229, 2017.
49